Functional mineralocorticoid receptor (MR) gene variation influences the cortisol awakening response after dexamethasone

Psychoneuroendocrinology

Volumn 35, Issue 3, 2010, Pages 339-349

  van Leeuwen, Nienke ^a   Kumsta, Robert ^b,c   Entringer, Sonja ^b,d   de Kloet, E Ronald ^a   Zitman, Frans G ^e   DeRijk, Roel H ^a,e   Wüst, Stefan ^b,f  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UNIVERSITY OF TRIER   (Germany)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Cortisol; Dexamethasone; Genetic variation; HPA axis; Mineralocorticoid receptor

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR;

ADULT; ANIMAL CELL; AROUSAL; ARTICLE; CONTROLLED STUDY; ETHNICITY; FEMALE; GENDER; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HORMONE ACTION; HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VITRO STUDY; MALE; NONHUMAN; NORMAL HUMAN; PLASMID; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS;

ADULT; ANIMALS; AROUSAL; CERCOPITHECUS AETHIOPS; COS CELLS; DEXAMETHASONE; FEMALE; GENOTYPE; HUMANS; HYDROCORTISONE; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, MINERALOCORTICOID; SALIVA; TRANSFECTION; WAKEFULNESS;

EID: 77649271021     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2009.07.006     Document Type: Article

References (61)

1. Ansseau M., Leboulle D., Sulon J., von Frenckell R., Legros J.J. Oral contraceptives and the dexamethasone suppression test. Psychoneuroendocrinology 1993, 18(1):37-43.
2. Arvat E., Maccagno B., Giordano R., Pellegrino M., Broglio F., Gianotti L., Maccario M., Camanni F., Ghigo E. Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans. J. Clin. Endocrinol. Metab. 2001, 86(7):3176-3181.
3. Atkinson H.C., Wood S.A., Castrique E.S., Kershaw Y.M., Wiles C.C.R., Lightman S.L. Corticosteroids mediate fast feedback of the rat hypothalamic-pituitary-adrenal axis via the mineralocorticoid receptor. Am. J. Physiol. Endocrinol. Metab. 2008, 294(6):E1011-E1022.
4. Backhaus J., Junghanns K., Hohagen F. Sleep disturbances are correlated with decreased morning awakening salivary cortisol. Psychoneuroendocrinology 2004, 29(9):1184-1191.
5. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265.
6. Bartels M., van den B.M., Sluyter F., Boomsma D.I., de Geus E.J. Heritability of cortisol levels: review and simultaneous analysis of twin studies. Psychoneuroendocrinology 2003, 28(2):121-137.
7. Bhagwagar Z., Hafizi S., Cowen P.J. Increase in concentration of waking salivary cortisol in recovered patients with depression. Am. J. Psychiatry 2003, 160(10):1890-1891.
8. Born J., Steinbach D., Dodt C., Fehm H.L. Blocking of central nervous mineralocorticoid receptors counteracts inhibition of pituitary-adrenal activity in human sleep. J. Clin. Endocrinol. Metab. 1997, 82(4):1106-1110.
9. Bradbury M.J., Akana S.F., Dallman M.F. Roles of type I and II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: evidence for a nonadditive effect of combined receptor occupation. Endocrinology 1994, 134(3):1286-1296.
10. Broderick J.E., Arnold D., Kudielka B.M., Kirschbaum C. Salivary cortisol sampling compliance: comparison of patients and healthy volunteers. Psychoneuroendocrinology 2004, 29(5):636-650.
11. Buckley T.M., Mullen B.C., Schatzberg A.F. The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls. Psychoneuroendocrinology 2007, 32(8-10):859-864.
12. Carey M.P., Deterd C.H., de Koning J., Helmerhorst F., de Kloet E.R. The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat. J. Endocrinol. 1995, 144(2):311-321.
13. Carroll B.J., Martin F.I.R., Davies B. Resistance to suppression by dexamethasone of Plasma 11-Ohcs levels in severe depressive illness. Br. Med. J. 1968, 3(5613):285-287.
14. Castren M., Patchev V.K., Almeida O.F., Holsboer F., Trapp T., Castren E. Regulation of rat mineralocorticoid receptor expression in neurons by progesterone. Endocrinology 1995, 136(9):3800-3806.
15. Chida Y., Steptoe A. Cortisol awakening response and psychosocial factors: a systematic review and meta-analysis. Biol. Psychol. 2009, 80:265-278.
16. Clow A., Thorn L., Evans P., Hucklebridge F. The awakening cortisol response: methodological issues and significance. Stress 2004, 7(1):29-37.
17. de Kloet R., Wallach G., McEwen B.S. Differences in corticosterone and dexamethasone binding to rat brain and pituitary. Endocrinology 1975, 96:598-609.
18. de Kloet E.R., Joels M., Holsboer F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 2005, 6(6):463-475.
19. DeRijk R.H., Wust S., Meijer O.C., Zennaro M.C., Federenko I.S., Hellhammer D.H., Giacchetti G., Vreugdenhil E., Zitman F.G., de Kloet E.R. A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. J. Clin. Endocrinol. Metab. 2006, 91(12):5083-5089.
20. Deuschle M., Weber B., Colla M., Muller M., Kniest A., Heuser I. Mineralocorticoid receptor also modulates basal activity of hypothalamus-pituitary-adrenocortical system in humans. Neuroendocrinology 1998, 68(5):355-360.
21. Dodt C., Kern W., Fehm H.L., Born J. Antimineralocorticoid canrenoate enhances secretory activity of the hypothalamus-pituitary-adrenocortical (HPA) axis in humans. Neuroendocrinology 1993, 58(5):570-574.
22. Dressendorfer R.A., Kirschbaum C., Rohde W., Stahl F., Strasburger C.J. Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement. J. Steroid Biochem. Mol. Biol. 1992, 43(7):683-692.
23. Droste S.K., de Groote L., Atkinson H.C., Lightman S.L., Reul J.M., Linthorst A.C.E. Corticosterone levels in the brain show a distinct ultradian rhythm but a delayed response to forced swim stress. Endocrinology 2008, 149(7):3244-3253.
24. Fries E., Dettenborn L., Kirschbaum C. The cortisol awakening response (CAR) facts and future directions. Int. J. Psychophysiol. 2008, 72(1):67-73.
25. Grossmann C., Scholz T., Rochel M., Bumke-Vogt C., Oelkers W., Pfeiffer A.F., Diederich S., Bahr V. Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells, a comparison of their glucocorticoid and mineralocorticoid properties. Eur. J. Endocrinol. 2004, 151(3):397-406.
26. Hellhammer J., Fries E., Schweisthal O.W., Schlotz W., Stone A.A., Hagemann D. Several daily measurements are necessary to reliably assess the cortisol rise after awakening: state- and trait components. Psychoneuroendocrinology 2007, 32(1):80-86.
27. Heuser I., Deuschle M., Weber A., Kniest A., Ziegler C., Weber B., Colla M. The role of mineralocorticoid receptors in the circadian activity of the human hypothalamus-pituitary-adrenal system: effect of age. Neurobiol. Aging 2000, 21(4):585-589.
28. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000, 23(5):477-501.
29. Joels M., Karst H., Derijk R., de Kloet E.R. The coming out of the brain mineralocorticoid receptor. Trends Neurosci. 2008, 31(1):1-7.
30. Karssen A.M., Meijer O.C., Berry A., Pinol R.S., de Kloet E.R. Low doses of dexamethasone can produce a hypocorticosteroid state in the brain. Endocrinology 2005, 146(12):5587-5595.
31. Karst H., Joels M. Corticosterone slowly enhances miniature excitatory postsynaptic current amplitude in mice CA1 hippocampal cells. J. Neurophysiol. 2005, 94(5):3479-3486.
32. Kirschbaum C., Kudielka B.M., Gaab J., Schommer N.C., Hellhammer D.H. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom. Med. 1999, 61(2):154-162.
33. Kovacs K.J., Foldes A., Sawchenko P.E. Glucocorticoid negative feedback selectively targets vasopressin transcription in parvocellular neurosecretory neurons. J. Neurosci. 2000, 20(10):3843-3852.
34. Kudielka B.M., Broderick J.E., Kirschbaum C. Compliance with saliva sampling protocols: electronic monitoring reveals invalid cortisol daytime profiles in noncompliant subjects. Psychosom. Med. 2003, 65(2):313-319.
35. Kudielka B.M., Kirschbaum C. Sex differences in HPA axis responses to stress: a review. Biol. Psychol. 2005, 69(1):113-132.
36. Kumsta R., Entringer S., Koper J.W., van Rossum E.F., Hellhammer D.H., Wüst S. Sex specific associations between common glucocorticoid receptor gene variants and hypothalamus-pituitary-adrenal axis responses to psychosocial stress. Biol. Psychiatry 2007, 62(8):863-869.
37. Kuningas M., de Rijk R.H., Westendorp R.G.J., Jolles J., Slagboom P.E., van Heemst D. Mental performance in old age dependent on cortisol and genetic variance in the mineralocorticoid and glucocorticoid receptors. Neuropsychopharmacology 2007, 32(6):1295-1301.
38. Meijer O.C., De Lange E.C.M., Breimer D.D., De Boer A.G., Workel J.O., de Kloet E.R. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 1998, 139(4):1789-1793.
39. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16(3):1215.
40. Minelli C., Thompson J.R., Abrams K.R., Thakkinstian A., Attia J. How should we use information about HWE in the meta-analyses of genetic association studies?. Int. J. Epidemiol. 2008, 37(1):136-146.
41. Otte C., Jahn H., Yassouridis A., Arlt J., Stober N., Maass P., Wiedemann K., Kellner M. The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone. Life Sci. 2003, 73(14):1835-1845.
42. Otte C., Yassouridis A., Jahn H., Maass P., Stober N., Wiedemann K., Kellner M. Mineralocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in aged humans. J. Gerontol. A: Biol. Sci. Med. Sci. 2003, 58(10):B900-B905.
43. Pascual-Le Tallec L., Demange C., Lombes M. Human mineralocorticoid receptor A and B protein forms produced by alternative translation sites display different transcriptional activities. Eur. J. Endocrinol. 2004, 150(4):585-590.
44. Portella M.J., Harmer C.J., Flint J., Cowen P., Goodwin G.M. Enhanced early morning salivary cortisol in neuroticism. Am. J. Psychiatry 2005, 162(4):807-809.
45. Pruessner M., Hellhammer D.H., Pruessner J.C., Lupien S.J. Self-reported depressive symptoms and stress levels in healthy young men: associations with the cortisol response to awakening. Psychosom. Med. 2003, 65(1):92-99.
46. Ratka A., Sutanto W., Bloemers M., de Kloet E.R. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology 1989, 50(2):117-123.
47. Roberts A.D., Wessely S., Chalder T., Papadopoulos A., Cleare A.J. Salivary cortisol response to awakening in chronic fatigue syndrome. Br. J. Psychiatry 2004, 184:136-141.
48. Rohleder N., Joksimovic L., Wolf J.M., Kirschbaum C. Hypocortisolism and increased glucocorticoid sensitivity of pro-inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder. Biol. Psychiatry 2004, 55(7):745-751.
49. Rupprecht R., Reul J.M., Van steensel B., Spengler D., Soder M., Berning B., Holsboer F., Damm K. Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands. Eur. J. Pharmacol. 1993, 247(2):145-154.
50. Schlotz W., Hellhammer J., Schulz P., Stone A.A. Perceived work overload and chronic worrying predict weekend-weekday differences in the cortisol awakening response. Psychosom. Med. 2004, 66(2):207-214.
51. Tajima T., Ma X.M., Bornstein S.R., Aguilera G. Prenatal dexamethasone treatment does not prevent alterations of the hypothalamic pituitary adrenal axis in steroid 21-hydroxylase deficient mice. Endocrinology 1999, 140(7):3354-3362.
52. Turner B.B. Sex difference in glucocorticoid binding in rat pituitary is estrogen dependent. Life Sci. 1990, 46(19):1399-1406.
53. Viau V., Chu A., Soriano L., Dallman M.F. Independent and overlapping effects of corticosterone and testosterone on corticotropin-releasing hormone and arginine vasopressin mRNA expression in the paraventricular nucleus of the hypothalamus and stress-induced adrenocorticotropic hormone release. J. Neurosci. 1999, 19(15):6684-6693.
54. von Have M., Oppelt P.G., Müller A., Beckmann M.W., Binder H. Kontrazeption. Geburtsh Frauenheilk 2005, 65(09):R173-R199.
55. Wellhoener P., Born J., Fehm H.L., Dodt C. Elevated resting and exercise-induced cortisol levels after mineralocorticoid receptor blockade with canrenoate in healthy humans. J. Clin. Endocrinol. Metab. 2004, 89(10):5048-5052.
56. Wessa M., Rohleder N., Kirschbaum C., Flor H. Altered cortisol awakening response in posttraumatic stress disorder. Psychoneuroendocrinology 2006, 31(2):209-215.
57. Wilhelm P., Born J., Kudielka B.M., Schlotz W., Wüst S. Is the cortisol awakening rise a response to awakening?. Exp. Clin. Endocrinol. Diabetes 2007, 115:S51.
58. Wüst S., Federenko I., Hellhammer D.H., Kirschbaum C. Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology 2000, 25(7):707-720.
59. Wüst S., Wolf J., Hellhammer D.H., Federenko I., Schommer N., Kirschbaum C. The cortisol awakening response-normal values and confounds. Noise Health 2000, 2(7):79-88.
60. Yehuda R. Post-traumatic stress disorder. N. Engl. J. Med. 2002, 346(2):108-114.
61. Young E.A., Lopez J.F., Murphy-Weinberg V., Watson S.J., Akil H. The role of mineralocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation in humans. J. Clin. Endocrinol. Metab. 1998, 83(9):3339-3345.